Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Conlon

Showing results (291-300 of 359) with videos related to

Pageof 36
Sort By:
Genomics|June 15, 1999
Linkage of a gene causing familial focal segmental glomerulosclerosis to chromosome 11 and further evidence of genetic heterogeneityM P Winn, P J Conlon, K L Lynn, et al.
Journal of the American Society of Nephrology : JASN|May 26, 2012
A hybrid CFHR3-1 gene causes familial C3 glomerulopathyTalat H Malik, Peter J Lavin, Elena Goicoechea de Jorge, et al.
Irish Journal of Medical Science|June 5, 2009
An assessment of the long-term health outcome of renal transplant recipients in IrelandA Al-Aradi, P J Phelan, P O'Kelly, et al.
Journal of Huntington'S Disease|October 16, 2018
Selective Neuronal Uptake and Distribution of AAVrh8, AAV9, and AAVrh10 in Sheep After Intra-Striatal AdministrationErica Mondo, Richard Moser, Guangping Gao, et al.
Gene Therapy|April 8, 2016
Reduced retinal transduction and enhanced transgene-directed immunogenicity with intravitreal delivery of rAAV following posterior vitrectomy in dogsR F Boyd, S L Boye, T J Conlon, et al.
Scandinavian Journal of Immunology|January 10, 2006
Immunomodulation in type 1 diabetes by NBI-6024, an altered peptide ligand of the insulin B epitopeD G Alleva, R A Maki, A L Putnam, et al.
Human Gene Therapy|April 11, 2013
Phase I/II trial of adeno-associated virus-mediated alpha-glucosidase gene therapy to the diaphragm for chronic respiratory failure in Pompe disease: initial safety and ventilatory outcomesBarbara K Smith, Shelley W Collins, Thomas J Conlon, et al.
Human Gene Therapy|November 23, 2006
Phase I trial of intramuscular injection of a recombinant adeno-associated virus serotype 2 alphal-antitrypsin (AAT) vector in AAT-deficient adultsMark L Brantly, L Terry Spencer, Margaret Humphries, et al.
Investigative Ophthalmology & Visual Science|October 25, 2014
LHON gene therapy vector prevents visual loss and optic neuropathy induced by G11778A mutant mitochondrial DNA: biodistribution and toxicology profileRajeshwari Koilkonda, Hong Yu, Venu Talla, et al.
Journal of Pain and Symptom Management|August 25, 2015
Understanding What Influences the Health-Related Quality of Life of Hemodialysis Patients: A Collaborative Study in England and IrelandAoife C Lowney, Helena T Myles, Katherine Bristowe, et al.
Pageof 36

Showing results (291-300 of 359) with videos related to

Sort By:
Pageof 36
Genomics|June 15, 1999
Linkage of a gene causing familial focal segmental glomerulosclerosis to chromosome 11 and further evidence of genetic heterogeneityM P Winn, P J Conlon, K L Lynn, et al.
Journal of the American Society of Nephrology : JASN|May 26, 2012
A hybrid CFHR3-1 gene causes familial C3 glomerulopathyTalat H Malik, Peter J Lavin, Elena Goicoechea de Jorge, et al.
Irish Journal of Medical Science|June 5, 2009
An assessment of the long-term health outcome of renal transplant recipients in IrelandA Al-Aradi, P J Phelan, P O'Kelly, et al.
Journal of Huntington'S Disease|October 16, 2018
Selective Neuronal Uptake and Distribution of AAVrh8, AAV9, and AAVrh10 in Sheep After Intra-Striatal AdministrationErica Mondo, Richard Moser, Guangping Gao, et al.
Gene Therapy|April 8, 2016
Reduced retinal transduction and enhanced transgene-directed immunogenicity with intravitreal delivery of rAAV following posterior vitrectomy in dogsR F Boyd, S L Boye, T J Conlon, et al.
Scandinavian Journal of Immunology|January 10, 2006
Immunomodulation in type 1 diabetes by NBI-6024, an altered peptide ligand of the insulin B epitopeD G Alleva, R A Maki, A L Putnam, et al.
Human Gene Therapy|April 11, 2013
Phase I/II trial of adeno-associated virus-mediated alpha-glucosidase gene therapy to the diaphragm for chronic respiratory failure in Pompe disease: initial safety and ventilatory outcomesBarbara K Smith, Shelley W Collins, Thomas J Conlon, et al.
Human Gene Therapy|November 23, 2006
Phase I trial of intramuscular injection of a recombinant adeno-associated virus serotype 2 alphal-antitrypsin (AAT) vector in AAT-deficient adultsMark L Brantly, L Terry Spencer, Margaret Humphries, et al.
Investigative Ophthalmology & Visual Science|October 25, 2014
LHON gene therapy vector prevents visual loss and optic neuropathy induced by G11778A mutant mitochondrial DNA: biodistribution and toxicology profileRajeshwari Koilkonda, Hong Yu, Venu Talla, et al.
Journal of Pain and Symptom Management|August 25, 2015
Understanding What Influences the Health-Related Quality of Life of Hemodialysis Patients: A Collaborative Study in England and IrelandAoife C Lowney, Helena T Myles, Katherine Bristowe, et al.
Pageof 36